Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability

scientific article published on 17 September 2006

Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BCP.2006.09.013
P698PubMed publication ID17054919

P2093author name stringSeulki Lee
Kang Choon Lee
Yu Seok Youn
Su Young Chae
Hyong Goo Shin
Jae Eun Jeon
P433issue1
P921main subjectproteolysisQ33123
P304page(s)84-93
P577publication date2006-09-17
P1433published inBiochemical PharmacologyQ864229
P1476titleEvaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability
P478volume73

Reverse relations

cites work (P2860)
Q47390545A 4-arm polyethylene glycol derivative conjugated with exendin-4 peptide and palmitylamine having dual-function of size-increase and albumin-binding for long hypoglycemic action
Q39537998A site-specific PEGylated analog of exendin-4 with improved pharmacokinetics and pharmacodynamics in vivo
Q38253931Commonality between Diabetes and Alzheimer's Disease and a New Strategy for the Therapy
Q39419837Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes
Q35087846Glucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.
Q42557469Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells
Q39569931Improving the anti-diabetic activity of GLP-1 by fusion with globular adiponectin
Q27023585Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?
Q90090310Preclinical evaluation of topically-administered PEGylated Fab' lung toxicity
Q38466742Preparation and evaluation of palmitic acid-conjugated exendin-4 with delayed absorption and prolonged circulation for longer hypoglycemia
Q38013190Strategies for non-invasive delivery of biologics

Search more.